Revance Therapeutics RVNC

Quarterly report 2024-Q3
added 11-07-2024

Revance Therapeutics Total Inventories 2011-2026 | RVNC

Annual Total Inventories Revance Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
45.6 M	18.3 M	10.2 M	5.88 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
45.6 M	5.88 M	20 M

Quarterly Total Inventories Revance Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
85.2 M	68.3 M	50.3 M	45.6 M	46.2 M	34.4 M	27.8 M	18.3 M	17.2 M	13.6 M	10.7 M	10.2 M	10.2 M	5.06 M	5.63 M	5.88 M	5.88 M	5.88 M	5.88 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
85.2 M	5.06 M	24.8 M

Total Inventories of other stocks in the Biotechnology industry

	Issuer	Total Inventories	Price	% 24h	Market Cap	Country
	Autolus Therapeutics plc AUTL	33.2 M	$ 1.36	-2.52 %	$ 362 M	Britain
	Acorda Therapeutics ACOR	16.2 M	-	-24.86 %	$ 820 K	USA
	Aytu BioScience AYTU	11.4 M	$ 2.6	-2.26 %	$ 16.3 M	USA
	Amicus Therapeutics FOLD	229 M	$ 14.46	0.03 %	$ 4.46 B	USA
	Gilead Sciences GILD	1.77 B	$ 138.34	-1.28 %	$ 172 B	USA
	Coherus BioSciences CHRS	3.17 M	$ 1.62	-3.29 %	$ 190 M	USA
	GT Biopharma GTBP	42 K	$ 0.41	-8.56 %	$ 2.26 M	USA
	Alnylam Pharmaceuticals ALNY	82.7 M	$ 316.69	-4.13 %	$ 41.5 B	USA
	Halozyme Therapeutics HALO	176 M	$ 63.72	1.01 %	$ 7.64 B	USA
	Harmony Biosciences Holdings HRMY	5.36 M	$ 27.53	-0.67 %	$ 1.58 B	USA